Herpes simplex virus (HSV) causes painful blisters and sores on the mouth or genitals. Treatment decreases outbreaks, but it cannot cure the infection. Genital herpes is a sexually transmitted ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...

A drug long used to fight cancer may soon take on a very different role. Researchers at the University of Illinois Chicago have found that doxorubicin, an FDA-approved chemotherapy medicine, can block ...

Valacyclovir is a generic prescription oral tablet used to treat herpes simplex infections. Its mechanism of action is to make it harder for the herpes virus to multiply. The herpes virus spreads in ...

LOS ANGELES (KABC) -- It's a pesky virus that affects two-thirds of the world population, but now USC researchers are turning the herpes simplex virus into an effective cancer fighter. One skin cancer ...

Approximately two-thirds of the world's population under the age of 50 years have oral or genital herpes simplex type 1 (HSV-1) infection, while one in eight have herpes simplex type 2 (HSV-2) ...

The Herpes simplex virus is a widespread virus that often causes cold sores, and most people carry it. By removing a virulence gene, i.e. a gene that makes the virus harmful to humans, the herpes ...

Kyle Donahue survived glioblastoma for five years after joining a clinical trial at Brigham and Women's Hospital. The trial used CAN-3110, an engineered herpes virus, to target and kill glioblastoma ...

Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ...

A genetically modified version of the virus behind cold sores might one day help people who’ve run out of other options. A modified herpesvirus combined with an immunotherapy drug shrank or eliminated ...

Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ...